TrialBreast cancer research and treatment2013
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.
Josefine Bostner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
64 papers cite itlatest 60 shown
this papertrialcites it